Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (15845)	2/25/1998 12:06:00 PM
From: Andreas Helke	Read Replies (2) of 32384

I suspect that with Targretin there is a factor that might make things a lot more complicated and difficult. Ligand intends to charge very high prices for Targretin as cancer treatment. I don't think that a type II diabetes patient is ready to pay the price that a cancer patient will gladly pay. If there will be a price difference and if the dosing range is comparable the cheaper diabetes treatment might be used off label to treat cancer. Or it might be necessary to lower the prices for Targretin when the diabetes indication gets approved in a few years. Does anybody know what doses are used for the various indications? Andreas

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next